|Articles|December 1, 2016
- Pharmaceutical Executive-12-01-2016
- Volume 36
- Issue 12
Pharmaceutical Executive, December 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Medical Game-Changers Beckonabout 9 years ago
Investing in Africa: How to Do It Rightabout 9 years ago
The Winning Edge in Emerging Marketsabout 9 years ago
Paula Apsell: A Storied Life in Scienceabout 9 years ago
Going to the Edgeabout 9 years ago
Trump Administration Offers Relief, and Challenges, for Pharmaabout 9 years ago
Executive Pay and Innovationabout 9 years ago
Science: The Communal Languageabout 9 years ago
Will NICE ‘Go Commercial’?about 9 years ago
Country Report: MexicoNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
2
GSK Enters Multi-Year Collaboration with Helix to Develop Precision Medications
3
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
4
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
5